Crossmark

Targeted nanoconjugate co-delivering siRNA and tyrosine kinase inhibitor to KRAS mutant NSCLC dissociates GAB1-SHP2 post oncogene knockdown

Published Online: 2016-08-17

Authors

Srikar, R.

Suresh, Dhananjay

Zambre, Ajit

Taylor, Kristen

Chapman, Sarah

Leevy, Matthew

Upendran, Anandhi

Kannan, Raghuraman
License Information

Text and Data Mining valid from 2016-08-17

Version of Record valid from 2016-08-17
More Information

Article History

Received: 22 March 2016

Accepted: 1 July 2016

First Online: 17 August 2016

Competing interests

: The authors declare no competing financial interests.

Document is current